Özlem ERTAN, Esma Sevil AKKURT, Tuğçe ŞAHİN ÖZDEMİREL, Berna AKINCI ÖZYÜREK

A rare case: acute ischemic stroke that developed in a case with severe COVID-19 pneumonia

The covid-19 infection causes involvements in many such as the central nervous system and causes prothrombotic complications. Viral neurotropism, endothelial dysfunction, coagulopathy, and inflammation are suggested mechanisms in the development of acute cerebrovascular disease in Covid-19 patients. The development of a neurological complication is a risk factor for mortality. Patients with high inflammatory markers need to be closely followed-up, because of the risk of the development of complications. It should be kept in mind that there may be neurological involvement in patients with symptoms such as headache, impaired consciousness, vertigo, drowsiness, and loss of strength. In this case, we aimed to present our patient who developed ischemic stroke while under treatment for severe Covid-19 pneumonia.

Keywords:

Covid-19, pneumonia, ischemic stroke,

PDF

___

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 145-51.
Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci 2020; 41: 1667-71.
Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol 2020; 77: 683-90.
Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med 2020; 38: 1549.e3-1549.e7.
Bodro M, Compta Y, Sánchez-Valle R. Presentations and mechanisms of CNS disorders related to COVID-19. Neurol Neuroimmunol Neuroinflamm 2020; 8: e923.
Annie F, Bates MC, Nanjundappa A, Bhatt DL, Alkhouli M. Prevalence and outcomes of acute ischemic stroke among patients ≤50 years of age with laboratory confirmed COVID-19 infection. Am J Cardiol 2020; 130: 169-70.
Vakili K, Fathi M, Pezeshgi A, et al. Critical complications of COVID-19: A descriptive meta-analysis study. Rev Cardiovasc Med 2020; 21: 433-42.
Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain 2020; 143: 3089-103.
Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 2020; 15: 385-9.
Tsivgoulis G, Palaiodimou L, Zand R, et al. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 2020; 13: 1756286420978004.
Azhideh A. COVID-19 Neurological manifestations. Int Clin Neurosci J 2020; 7; 2: 54.
Goldberg MF, Goldberg MF, Cerejo R, Tayal AH. Cerebrovascular disease in COVID-19. Am J Neuroradiol 2020; 41; 1170-2.
Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 2020; 95: 1060-70.
Reddy ST, Garg T, Shah C, et al. Cerebrovascular disease in patients with COVID-19: a review of the literature and case series. Case Rep Neurol 2020; 12; 199-209.
Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18-22.
Wang F, Nie J, Wang H, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv 2020: 2020.02.10.20021832.
Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 2020; 5: 279-84.